Mike Pence on Leadership and the Future of the Republican Party
Former US Vice President Mike Pence looks back on the events of January 6 2021, his final days in office with President Trump and his…
Thought Leader: Mike Pence
By Sanjay Gupta (Original source CNN)
“Veteran doctors don’t need a blood test to tell when someone is on the verge of a drug overdose. They can even narrow down the culprit by observation alone. Dilated pupils mean cocaine, amphetamines, maybe LSD. Constricted pupils mean an opiate.
Additionally, an opiate abuser is characteristically “nodding out” and often scratching their itchy skin. While their face is becoming pale and clammy, their fingernails and lips are starting to turn blue or even a sickly purplish-black. When the choking noises — or the deep snore gurgling sounds, known as the death rattle — begin, it’s time to act, and fast. That is a pretty clear sign the opiates have just turned off the person’s drive to breathe and they are in the throes of an overdose.
It is an awful sight, and yet more than 130 people die every day in this country after overdosing on any type of opioid. There is no other medication routinely used for a nonfatal condition that kills patients so frequently. Deaths result from prescription opioid medications, such as hydrocodone, OxyContin and Percocet.”
Click here to see more
Mike Pence on Leadership and the Future of the Republican Party
Former US Vice President Mike Pence looks back on the events of January 6 2021, his final days in office with President Trump and his…
Thought Leader: Mike Pence
Marc Short on U.S. Investment in Critical Minerals
Why do critical minerals matter now? Marc Short explains how U.S. investment in critical minerals fits into a broader strategy around economic security, manufacturing, and…
Thought Leader: Marc Short
Marc Short on AI Policy and the Government’s Role in Chip Technology Investment
On CNBC, Marc Short breaks down the role of AI policy and how government investment is shaping the future of chip technology. A former Chief…
Thought Leader: Marc Short